The exit of pharmaceutical multinationals from Nigeria last year has been identified as an opportunity that existing companies will explore to expand their market share in 2024 as analysts anticipate an increase in pharmaceutical and consumer health product prices. Meristem in its outlook for the
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp